Back to Search Start Over

115 The frequency of intermediate monocytes before treatment is a candidate biomarker of clinical response to secukinumab in of psoriasis

Authors :
Hardman-Smart, J.
Ejarque, R. Andres
Solanky, S.
Tosi, I.
Grys, K.
Barker, J.
Griffiths, C.
Reynolds, N.J.
Smith, C.
Warren, R.B.
Di Meglio, P.
Consortium, P.
Source :
Journal of Investigative Dermatology; December 2022, Vol. 142 Issue: 12, Number 12 Supplement 1 pS200-S200, 1p
Publication Year :
2022

Details

Language :
English
ISSN :
0022202X and 15231747
Volume :
142
Issue :
12, Number 12 Supplement 1
Database :
Supplemental Index
Journal :
Journal of Investigative Dermatology
Publication Type :
Periodical
Accession number :
ejs61917317
Full Text :
https://doi.org/10.1016/j.jid.2022.09.125